Skip to content
Research Article Open access CC BY 4.0

Vancomycin Resistant Enterococci Infections in Trinidad and Tobago

Shivnarine Kissoon, Patrick Eberechi Akpaka, William Henry Swanston

Microbiology Research Journal International · pp. 1–8 · Published 18 Jun 2015

10.9734/BMRJ/2015/18531

Abstract

Aims: To document Vancomycin Resistant Enterococci (VRE) infections prevalence, risk factors, antimicrobial susceptibility patterns and evaluation of chromogenic plates in identifying VRE isolates in Trinidad and Tobago. Study Design: This was a cross sectional prospective observational and descriptive study. Place and Duration of Study: Study was carried out in all major regional hospitals in Trinidad & Tobago over a four year period, 2009 to 2013. Methodology: All cases of Enterococcus infections from major hospitals in the country were reviewed. Standardized questionnaire was used to analyze epidemiological and clinical data of VRE infected patients. Enterococcal speciation, minimum inhibitory concentrations (MIC) were evaluated using Microscan Walk Away 96SI (Siemens, USA). Isolates were further identified using 6.5% NaCl and pyrrolidonyl arylamidase activity according to CLSI guidelines. Brain Heart Infusion agar, Bile esculin azide agar containing 6 mg/L of vancomycin and chromogenic agar plates - Chromagar VRE and chrom ID VRE were used to screen and confirm VRE isolates Results: A low (3.9%) VRE infections were encountered from 1,141 enterococcal infections reviewed. Majority of these infections occurred in the surgical facilities (42%) and least from the burns unit (2%) respectively. No significant association was observed between VRE infections and patients’ gender, age, wards or hospital facilities. However underlying diseases such as diabetes mellitus and hypertension; and prior use of antibiotics on or before admission were noted to be associated with the VRE infections. All the VRE infections were mainly caused by E. faecium and E. faecalis that were completely (100%) resistant to ciprofloxacin, erythromycin, levofloxacin, rifampin and vancomycin, but were 95% and 100% susceptible to gentamycin and linezolid respectively. Overall, performance of the chromogenic agar plates were 100% sensitive and specific for VRE Conclusion: In Trinidad & Tobago VRE infections prevalence although low are strongly associated with high antibiotic consumption, prolonged hospitalization and diabetes mellitus disease. Linezolid is highly susceptible to multidrug resistant VRE isolates in the country. Chromogenic VRE media produced rapid and reliable identification of VRE organism. Further use of molecular studies to monitor the epidemiology of VRE infections in hospitals in the country is highly recommended.

Chromogenic agar diabetes mellitus Enterococcus faecium Enterococcus faecalis VRE infections Trinidad & Tobago

References (20)

  1. 1 Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Annual Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006–2007 [DOI]
  2. 2 The life and times of the Enterococcus [DOI]
  3. 3 Plasmid-Mediated Resistance to Vancomycin and Teicoplanin in Enterococcus Faecium [DOI]
  4. 4 Determinants of Vancomycin Resistance and Mortality Rates in Enterococcal Bacteremia: A Prospective Multicenter Study [DOI]
  5. 5 Changing trends in vancomycin-resistant enterococci in French hospitals, 2001-08 [DOI]
  6. 6 High-level vancomycin-resistant enterococci causing hospital infections [DOI]
  7. 7 Spread of ampicillin/vancomycin-resistant Enterococcus faecium of the epidemic-virulent clonal complex-17 carrying the genes esp and hyl in German hospitals [DOI]
  8. 8 Enterococcal Bacteremia: Risk Factors for Vancomycin Resistance and Predictors of Mortality [DOI]
  9. 9 Vancomycin-Resistant Enterococci [DOI]
  10. 10 Enterococci increase the morbidity and mortality associated with severe intra-abdominal infections in elderly patients hospitalized in the intensive care unit [DOI]
  11. 11 Molecular Characterization of Vancomycin-Resistant Enterococcus faecium Isolates from Korea [DOI]
  12. 12 Outbreak of Vancomycin-Susceptible Enterococcus faecium Containing the Wild-Type vanA Gene [DOI]
  13. 13 Molecular epidemiology of vancomycin-resistant Enterococcus faecium in Argentina [DOI]
  14. 14 Novel Chromogenic Medium for Detection of Vancomycin-Resistant Enterococcus faecium and Enterococcus faecalis [DOI]
  15. 15 Comparison of Performance of the Novel Chromogenic Spectra VRE Agar to That of Bile Esculin Azide and Campylobacter Agars for Detection of Vancomycin-Resistant Enterococci in Fecal Samples [DOI]
  16. 16 Vancomycin-resistant Enterococci in Singaporean Hospitals: 5-year results of a Multi-centre Surveillance Programme [DOI]
  17. 17 Risk Factors for Colonization With Vancomycin-Resistant Enterococci in a Melbourne Hospital [DOI]
  18. 18 Control of vancomycin-resistant enterococci in a hospital: a five-year experience in a Taiwanese teaching hospital [DOI]
  19. 19 Methicillin-resistant Staphylococcus aureus Control in Singapore – Moving Forward [DOI]
  20. 20 Manual of Clinical Microbiology. [DOI]

Cited by 5

Showing 4 of 5 known citations — external sources report more than can currently be individually listed.

Article metrics

Real usage data collected on this platform.

74

Page views

0

PDF downloads

27

Outbound clicks

5

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.